Clinical immunotherapy of B-cell malignancy using CD19-targeted CAR T-cells.
about
Genetically modified T cells in cancer therapy: opportunities and challengesDesign and applications of bispecific heterodimers: molecular imaging and beyondmRNA-based dendritic cell vaccines.CD19: A multifunctional immunological target molecule and its implications for Blineage acute lymphoblastic leukemia.ErbB-targeted CAR T-cell immunotherapy of cancer.Anti-CD19 chimeric antigen receptor-modified T cells for B-cell malignancies: a systematic review of efficacy and safety in clinical trials.Prospects for adoptive immunotherapy of pancreatic cancer using chimeric antigen receptor-engineered T-cells.CAR T-cell immunotherapy: The path from the by-road to the freeway?Chimeric antigen receptor T cells for the treatment of cancer and the future of preclinical models for predicting their toxicities.Current status and regulatory perspective of chimeric antigen receptor-modified T cell therapeutics.Mesothelin-targeting chimeric antigen receptor-modified T cells by piggyBac transposon system suppress the growth of bile duct carcinoma.'Atypical' CAR T cells: NKG2D and Erb-B as examples of natural receptor/ligands to target recalcitrant solid tumors.Evaluation of cost effective diagnostic tools in characterisation of Acute Leukemia in Southern India.Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy - Moving Target for Industry?Synergizing Engineered Immunotherapy with Molecularly Targeted Cancer Treatment
P2860
Q27026627-35C15DB2-3093-43F7-884C-DDD27026BC55Q33732587-ED2A48C5-C494-4568-97A1-6F1AD64F7B27Q38246769-98415A02-1116-4841-9E27-454820D2B609Q38371387-E6F84805-4FA2-42DC-AF63-5F8C01948433Q38389298-8CDD70C6-00B1-4758-8FB0-ADF671E2C258Q38538645-D79BD176-43E6-40B0-A459-EF4B57845E98Q38608986-0CFB7028-B2FC-498C-985C-7B733A00B0F8Q38632105-59B9B33A-5F57-4144-8F83-91488DA57FECQ38666256-533030F4-7E0C-4A35-A81D-134E4F906C76Q38741113-137BEF50-EED1-49C4-9646-2409099DBF64Q40256333-CA72D26C-540E-40A6-AA54-57A862FA1B55Q47849932-C6A9B1A0-F400-45F8-9472-3C65EEB08099Q53121831-BDD8416D-050A-499E-BCE9-022D2BF7A0F4Q55043332-5169C851-AC11-47B3-8A21-82BCCE0405CDQ56970013-A97EACDA-12FB-40A1-97B1-FC8E45359E4D
P2860
Clinical immunotherapy of B-cell malignancy using CD19-targeted CAR T-cells.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Clinical immunotherapy of B-cell malignancy using CD19-targeted CAR T-cells.
@en
type
label
Clinical immunotherapy of B-cell malignancy using CD19-targeted CAR T-cells.
@en
prefLabel
Clinical immunotherapy of B-cell malignancy using CD19-targeted CAR T-cells.
@en
P1433
P1476
Clinical immunotherapy of B-cell malignancy using CD19-targeted CAR T-cells.
@en
P356
10.2174/1566523213666131223130554
P407
P50
P577
2014-02-01T00:00:00Z